SYSTEMATIC REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1625735
Effect of Antioxidants on Primary Open-Angle Glaucoma: A Systematic Review and Meta-Analysis
Provisionally accepted- 1School of Ophthalmology, Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 2Other
- 3Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background/Objectives: Primary open-angle glaucoma is a major global cause of vision loss, severely impacting quality of life. Although the need for effective treatments is widely recognized, the efficacy and safety of antioxidants remain uncertain. In this systematic review and meta-analysis, we aimed to evaluate the efficacy and safety of antioxidants in treating patients with primary open-angle glaucoma. Methods: We reviewed studies from PubMed, Embase, Cochrane Library, and Web of Science published up to November 30, 2024. Eligible studies included adults aged 18–80 years with primary open-angle or normal-tension glaucoma, comparing antioxidant treatment with placebo or comparing a combination of topical treatment and antioxidants with topical treatment alone. Only randomized controlled trials and crossover trials were included. Studies involving secondary glaucoma, ocular inflammation, trauma, or severe systemic disease were excluded, as were nonhuman studies. Of the 518 studies, 15 (2.9%) met the final criteria. Data abstraction and quality assessment followed established guidelines for rigor and transparency. The study outcomes—intraocular pressure, visual field deterioration, ocular blood circulation, blood pressure, and adverse effects—were chosen to evaluate the efficacy and safety of antioxidant treatments in primary open-angle glaucoma. Results: Analysis of 15 studies showed that antioxidant supplementation reduces intraocular pressure, improves visual field mean deterioration, and enhances ocular blood circulation in patients with primary open-angle glaucoma. No significant differences were observed in blood pressure or adverse effects between the treatment and placebo groups. Conclusion: This meta-analysis highlights the potential role of antioxidants as a safe and effective therapeutic option for patients with primary open-angle glaucoma.
Keywords: Antioxidants, Primary open-angle glaucoma, Normal-tension glaucoma, Meta-analysis, randomized controlled trials
Received: 16 May 2025; Accepted: 25 Aug 2025.
Copyright: © 2025 Bao, Yu, Chen, Hu, Zhao and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiang Li, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.